NEWS

Right MCA aneurysm

Bilateral sigmoid sinuses stenosis

Follow the LINNC online LikedIn page!

Corindus Announces FDA Submission for Neurovascular Intervention Indicat...

Expansion of CorPath GRX into neurovascular intervention could mark first step in revolutionizing stroke treatmentWALTHAM, MA — February 14, 2019 — Corindus Vascular Robotics (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today it is seeking premarket clearance from the U.S. Food and Drug Administration (FDA) to use the CorPath GRX System in neurovascular intervention. CorPath GRX, the second generation robotic platform, received FDA clearance for percutaneous coronary intervention (PCI) in 2016 and peripheral vascular intervention (PVI) in 2018. Upon successful FDA clearance, CorPath GRX would become the world’s first and only robotic platform indicated for use in PCI, PVI and neurovascular intervention (NVI).

Comparison of pipeline embolization device sizing based on conventional...

An agreement study

Aneurysm treated with coils and flow diverter

FDA expands indications for Medtronic’s Pipeline Flex embolization device

Medtronic said today it won expanded FDA approval for its Pipeline Flex embolization device.

Spinal extradural arteriovenous fistula

Sim&Size: 1500+ successful simulations in 2018!

 Sim&Cure is honoured and proud to announce that Sim&Size reached 1500 patient cases at the end of 2018! We are thankful to our clients and partners Medtronic, Microvention, Cerenovus, Balt, Phenox, Stryker and to each neurointerventionist that choose Sim&Size to support their interventional cases.Sim&Cure starts 2019 with a lot of excitement; working on new Sim&Size releases, waiting for the FDA approval, develop the use of Sim&Size in new countries and still more cases to come on the Asian, African, American and European continent! www.sim-and-cure.com

Endovascular patch embolization